Knockdown of PRKD2 Enhances Chemotherapy Sensitivity in Cervical Cancer Via the TP53/CDKN1A Pathway.
Current Cancer Drug Targets(2022)
Key words
Cervical cancer,chemotherapy sensitivity,PRKD2,TP53,CDKN1A pathway,whole exome sequencing,drug resistance
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined